- cafead   May 25, 2023 at 01:02: PM
via Following a strategic review, British AI drug discovery company BenevolentAI announced a reorganization initiative Thursday aimed at optimizing its pipeline and technology platforms to reduce its expenditures and maximize value for stakeholders.
article source
article source